Prospective study of hepatocellular carcinoma and liver cirrhosis in asymptomatic chronic hepatitis B virus carriers

American Journal of Epidemiology

Volumn 145, Issue 11, 1997, Pages 1039-1047

  Yu, Ming Whei ^a   Hsu, Fang Chi ^a   Sheen, I Shyan ^b   Chu, Chia Ming ^b   Lin, Deng Yn ^b   Chen, Chien Jen ^a   Liaw, Yun Fan ^b  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

carcinoma; hepatitis B surface antigen carriers; hepatocellular; liver cirrhosis; prospective studies; risk factors; smoking

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN;

ADULT; ALCOHOL CONSUMPTION; AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CIGARETTE SMOKING; COHORT ANALYSIS; CONTROLLED STUDY; HEPATITIS B VIRUS; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; REAL TIME ECHOGRAPHY; TAIWAN; VIRUS CARRIER;

EID: 0030919894     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.aje.a009060     Document Type: Article

References (36)

1. Liaw YF, Tai DI, Chu CM, et al. Early detection of hepatocellular carcinoma in patients with chronic type B hepatitis. Gastroenterology 1986;90:263-7.
2. Oka H, Kurioka N, Kim K, et al. Prospective study of early detection of hepatocellular carcinoma in patients with cirrhosis. Hepatology 1990;12:680-7.
3. Adachi E, Maeda T, Matsumata T, et al. Risk factors for intrahepatic recurrence in human small hepatocellular carcinoma. Gastroenterology 1995;108:768-75.
4. Colombo M, De Franchis R, Del Ninno E, et al. Hepatocellular carcinoma in Italian patients with cirrhosis. N Engl J Med 1991;325:675-80.
5. Kato Y, Nakata K, Omagari K, et al. Risk of hepatocellular carcinoma in patients with cirrhosis in Japan. Cancer 1994; 74:2234-8.
6. Liaw YF, Tai DI, Chu CM, et al. The development of cirrhosis in patients with chronic type B hepatitis: a prospective study. Hepatology 1988;8:493-6.
7. Popper H, Shafritz DA, Hoofnagle JH. Relation of the hepatitis B virus carrier state to hepatocellular carcinoma. Hepatology 1987;7:764-72.
8. Klatsky AL, Armstrong MA. Alcohol, smoking, coffee, and cirrhosis. Am J Epidemiol 1992;136:1248-57.
9. Corrao G, Ferrari PA, Galatola G. Exploring the role of diet in modifying the effect of known disease determinants: application to risk factors of liver cirrhosis. Am J Epidemiol 1995; 142:1136-46.
10. Yu MW, Chen CJ. Hepatitis B and C viruses in the development of hepatocellular carcinoma. Crit Rev Oncol Hematol 1994;17:71-91.
11. Beasley RP. Hepatitis B virus: the major etiology of hepatocellular carcinoma. Cancer 1988;61:1942-56.
12. Lin DY, Sheen IS, Chiu CT, et al. Ultrasonographic changes of early liver cirrhosis in chronic hepatitis B: a longitudinal study. J Clin Ultrasound 1993;21:303-8.
13. Chan SH, Simons MJ, Oon CJ. HLA antigen in Chinese patients with hepatocellular carcinomas. J Natl Cancer Inst 1980;65:21-3.
14. Medhat A, Iber FL, Dunne M. A new quantitative ultrasonic method for diagnosis of chronic parenchymal liver disease. Gastroenterology 1988;94:157-62.
15. Dragosics B, Ferenci P, Hitchman E, et al. Long-term follow-up study of asymptomatic HBsAg-positive voluntary blood donors in Austria: a clinical and histologic evaluation of 242 cases. Hepatology 1987;7:302-6.
16. Fattovich G, Rugge M, Brollo L, et al. Clinical, virologic, and histologic outcome following seroconversion from HBeAg to anti-HBe in chronic hepatitis type B. Hepatology 1986;6: 167-72.
17. Nielsen JO, Dietrichson O, Juhl E. Incidence and meaning of the "e" determinant among hepatitis-B-antigen positive patients with acute and chronic liver diseases: report from the Copenhagen Hepatitis Acuta Programme. Lancet 1974;2: 913-15.
18. Hindman SH, Gravelle CR, Murphy BL, et al. "e" Antigen, Dane particles, and serum DNA polymerase activity in HBsAg carriers. Ann Intern Med 1976;85:458-60.
19. Trepo CG, Magnius LO, Schaefer RA, et al. Detection of e antigen and antibody: correlations with hepatitis B surface and hepatitis B core antigens, liver disease, and outcome in hepatitis B infections. Gastroenterology 1976;71:804-8.
20. Tong MJ, Stevenson D, Gordon I. Correlation of e antigen, DNA polymerase activity, and Dane particles in chronic benign and chronic active type B hepatitis infections. J Infect Dis 1977;135:980-4.
21. Liaw YF, Chu CM, Lin DY, et al. Age-specific prevalence and significance of hepatitis B e antigen and antibody in chronic hepatitis B virus infection in Taiwan. J Med Virol 1984;13: 385-91.
22. Liaw YF, Chu CM, Su IJ, et al. Clinical and histological events preceding hepatitis B e antigen seroconversion in chronic type B hepatitis. Gastroenterology 1983;84:216-19.
23. Chen CJ, Yu MW, Wang CJ, et al. Multiple risk factors of hepatocellular carcinoma: a cohort study of 13,737 male adults in Taiwan. J Gastroenterol Hepatol Suppl 1993;8: s83-s87.
24. Yu MW, Chen CJ, Luo JC, et al. Correlations of chronic hepatitis B virus infection and cigarette smoking with elevated expression of neu oncoprotein in the development of hepatocellular carcinoma. Cancer Res 1994;54:5106-10.
25. Yu MW, Gladek-Yarborough A, Chiamprasert S, et al. Cytochrome P450 2E1 and glutathione S-transferase M1 polymorphisms and susceptibility to hepatocellular carcinoma. Gastroenterology 1995;109:1266-73.
26. Wehner AP, Busch RH, Olson RJ. Effects of diethylnitrosamine and cigarette smoke on hamsters. J Natl Cancer Inst 1976;56:749-56.
27. Barton SE, Jenkins D, Cuzick J, et al. Effect of cigarette smoking on cervical epithelial immunity: a mechanism for neoplastic change? Lancet 1988;2:652-4.
28. Miller LG, Goldstein G, Murphy M, et al. Reversible alterations in immunoregulatory T cells in smoking. Chest 1982; 5:527-9.
29. Rasp FL, Clawson CC, Hoidal R, et al. Reversible impairment of the adherence of alveolar macrophages from cigarette smokers. Am Rev Respir Dis 1978;118:979-86.
30. Skog OJ. The wetness of drinking cultures: a key variable in epidemiology of alcoholic liver cirrhosis. Acta Med Scand Suppl 1985;703:157-84.
31. Lieber CS, Garro A, Leo MA, et al. Alcohol and cancer. Hepatology 1986;6:1005-19.
32. Tanaka K, Hirohata T, Koga S, et al. Hepatitis C and hepatitis B in the etiology of hepatocellular carcinoma in the Japanese population. Cancer Res 1991;51:2842-7.
33. Yu MW, You SL, Chang AS, et al. Association between hepatitis C virus antibodies and hepatocellular carcinoma in Taiwan. Cancer Res 1991;51:5621-5.
34. Arico S, Aragona M, Rizzetto M, et al. Clinical significance of antibody to the hepatitis delta virus in symptomless HBsAg carriers. Lancet 1985;2:356-8.
35. Wu JC, Choo KB, Chen CM, et al. Genotyping of hepatitis D virus by restriction-fragment length polymorphism and relation to outcome of hepatitis D. Lancet 1995;346:939-41.
36. Liaw YF, Lin HH, Chu CM, et al. Hepatitis delta virus infection in Taiwan. In: Rizzetto M, Gerin JL, Purcell RH, eds. The hepatitis delta virus and its infection. New York: Alan R Liss, 1987:479-83.